Skip to content
Screener

Cognition Therapeutics, Inc. CGTX Q2 2026 earnings

Reported August 6, 2026 · After market close

EPS-$0.04Beat by $0.02
Revenue estimate$5.0M
EPS estimate-$0.06

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$5.3M
EPS estimate-$0.07

FAQ

When did Cognition Therapeutics, Inc. report Q2 2026 earnings?
Cognition Therapeutics, Inc. (CGTX) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Cognition Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Cognition Therapeutics, Inc. reported eps of $-0.04 for Q2 2026.
Did Cognition Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.06 by $0.02.
How did Cognition Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 63.6% from $-0.11.
Where can I find Cognition Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-092037) and the 10-Q periodic report (0001104659-26-092362) directly on SEC EDGAR. The filing index links above go to sec.gov.